Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) EBIT Margin (2016 - 2025)

Historic EBIT Margin for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to 189.59%.

  • HealthLynked's EBIT Margin rose 936300.0% to 189.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 130.56%, marking a year-over-year increase of 212500.0%. This contributed to the annual value of 155.49% for FY2024, which is 829400.0% down from last year.
  • HealthLynked's EBIT Margin amounted to 189.59% in Q3 2025, which was up 936300.0% from 115.26% recorded in Q2 2025.
  • HealthLynked's EBIT Margin's 5-year high stood at 178.15% during Q4 2021, with a 5-year trough of 295.1% in Q4 2022.
  • For the 5-year period, HealthLynked's EBIT Margin averaged around 105.41%, with its median value being 112.73% (2022).
  • In the last 5 years, HealthLynked's EBIT Margin surged by 2440700bps in 2021 and then plummeted by -4732500bps in 2022.
  • Over the past 5 years, HealthLynked's EBIT Margin (Quarter) stood at 178.15% in 2021, then crashed by -266bps to 295.1% in 2022, then surged by 60bps to 119.43% in 2023, then decreased by -1bps to 120.98% in 2024, then crashed by -57bps to 189.59% in 2025.
  • Its EBIT Margin was 189.59% in Q3 2025, compared to 115.26% in Q2 2025 and 120.3% in Q1 2025.